A Pyroptosis-Related Gene Signature to Predict Patients’ Prognosis and Immune Landscape in Liver Hepatocellular Carcinoma

Figure 8

The OS curves of high-risk group and low-risk group based on the subgroups of age (a), gender (b), tumor grade (c), clinical stage (d, e), T stage (f, g), N stage (h, i), and M stage (j, k).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)